Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis

Chest

Volumn 136, Issue 6, 2009, Pages 1561-1568

  Laguna, Theresa A ^a   Wagner, Brandie D ^b   Luckey, Heidi K ^c,d   Mann, Shelley A ^c,d   Sagel, Scott D ^c,d   Regelmann, Warren ^a   Accurso, Frank J ^c,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Global Health and Health Disparities   (United States)

^c Children's Hospital Colorado   (United States)

^d CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIFUNGAL AGENT; AZITHROMYCIN; C REACTIVE PROTEIN; CEPHALOSPORIN; DESMOSINE; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG INJURY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHOOL CHILD; SPUTUM; SPUTUM CULTURE;

EID: 73149122130     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0217     Document Type: Article

References (35)

1. Welsh MJ, Ramsey BW, Accurso FJ, et al. Metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw Hill, 2001; 521-588
2. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95:1005-1017
3. Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 2007; 4:406-417
4. Chmiel JF, Berger M, Konstan MW. The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol 2002; 23:5-27
5. Kahn TZ, Wagener JS, Bost T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 2001; 151:1075-1082
6. Tiddens HAWM, de Jong PA. Imaging and clinical trials in cystic fibrosis. Proc Am Thorac Soc 2007; 4:343-346
7. Ranganathan SC, Dezateux C, Bush A, et al. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001; 358:1964-1965
8. Que C, Cullinan P, Geddes D. Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax 2006; 61:155-157
9. Smith AL, Redding G, Doershuk C, et al. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr 1988; 112:547-554
10. Ordonez CL, Henig NR, Mayer-Hamblett N, et al. Inflammation and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med 2003; 168:1471-1475
11. Downey DG, Brockbank S, Martin SL, et al. The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation. Pediatr Pulmonol 2007; 42:729-735
12. Ma S, Lieberman S, Turino GM, et al. The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc Natl Acad Sci U S A 2003; 100:12941-12943
13. Ma S, Lin YY, Turino GM. Measurements of desmosine and isodesmosine by mass spectrometry in COPD. Chest 2007; 131:1363-1371
14. Boschetto P, Quintavalle S, Zeni E, et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 2006; 61:1037-1042
15. Stone PJ, Konstan MW, Berger M, et al. Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am J Respir Crit Care Med 1995; 152:157-162
16. Bruce MC, Poncz L, Klinger JD, et al. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985; 132:529-535
17. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998; 132:589-595
18. Sagel SD, Kapsner R, Osberg I, et al. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med 2001; 164: 1425-1431
19. King GS, Mohan VS, Starcher BC. Radioimmunoassay for desmosine. Connect Tissue Res 1980; 7:263-267
20. Starcher B, Green M, Scott M. Measurement of urinary desmosine as an indicator of acute pulmonary disease. Respiration 1995; 62:252-257
21. Starcher BC, Conrad M. A role for neutrophil elastase in the progression of solar elastosis. Connect Tissue Res 1995; 31:133-140
22. Starcher BC. A ninhydrin-based assay to quantitate the total protein content of tissue samples. Anal Biochem 2001; 292: 125-129
23. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
24. Thiebaut R, Jacqmin-Gadda H, Chene G, et al. Bivariate linear mixed models using SAS proc MIXED. Comput Methods Programs Biomed 2002; 69:249-256
25. Griesenbach U, Jeswiet SB, Larsen MD, et al. UK CF Gene Therapy Consortium Tracking Study: change in sputum properties in response to IV antibiotic. Pediatr Pulmonol Suppl 2007; 42:229
26. Starcher B, Peterson B. The kinetics of elastolysis: elastin catabolism during experimentally induced fibrosis. Exp Lung Res 1999; 25:407-424
27. Mercer RR, Crapo JD. Spatial distribution of collagen and elastin fibers in the lungs. J Appl Physiol 1990; 69:756-765
28. Starcher BC. Lung elastin and matrix. Chest 2000; 117:229-234
29. Hilliard TN, Regamey N, Shute JK, et al. Airway remodeling in children with cystic fibrosis. Thorax 2007; 62:1074-1080
30. Bode DC, Pagani ED, Cumiskey WR, et al. Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosis. Pulm Pharmacol Ther 2000; 13:175-180
31. Starcher B, Green M, Scott M. Measurement of urinary desmosine as an indicator of acute pulmonary disease. Respiration 1995; 62:252-257
32. Downey DG, Martin SL, Dempster M, et al. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Pediatr Pulmonol 2007; 42:216-220
33. Kuhn C III, Engleman W, Chraplyvy M, et al. Degradation of elastin in experimental elastase-induced emphysema measured by a radioimmunoassay for desmosine. Exp Lung Res 1983; 5:115-123
34. Luisetti M, Ma S, Iadarola P, et al. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 2008; 32:1146-1157
35. Mayer-Hamblett N, Ramsey BW, Kronmal RA. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc Am Thorac Soc 2007; 4:370-377